Business Wire

Xlife Sciences AG: Breakthrough in Drug Development

Share

Xlife Sciences AG (XLS DE): Breakthrough in Drug Development First available holistic medical drug to treat Covid-19 and flu viruses As a project company of Xlife Sciences AG (XLS DE), inflamed pharma GmbH has developed a revolutionary and holistic therapeutic approach to treat both SARS-CoV-2 and flu viruses. The patented active substance ProcCluster(R) reduces the viral load by 90% and acts against infection-related inflammatory processes without developing a resistance. It is already used on humans. The active pharmaceutical ingredient ProcCluster(R) developed by inflamed pharma GmbH is membrane permeable and is based on the active ingredient procaine. It acts both locally as well as systemically and is characterized by a wide range of applications in inflammatory diseases. ProcCluster(R) is already used for various prescription drugs for humans. In various case studies, renowned medical doctors have now been able to successfully demonstrate the effectiveness in the treatment of Covid-19 and Long-Covid patients. In studies with various cell lines, especially lung cells, the active ingredient was able to reduce the viral load by 90% in an early phase and effectively inhibit inflammation in a later phase. These effects can be transferred to other RNA viruses. Oliver R. Baumann, CEO of Xlife Sciences AG, comments: "ProcCluster(R) has enormous market potential because, in contrast to other active ingredients, both the inflammatory processes and the viral load in the body are significantly reduced. This means that it can be used at different points in time during the course of the Covid-19 disease". It is of inestimable value that this active ingredient is already produced by inflamed pharma GmbH in high quality at low cost. "Another key advantage compared to vaccines and antibodies is that ProcCluster(R) does not lead to resistance development and can also be used against virus mutants", continues Baumann. In addition, ProcCluster(R) has a stimulating effect on the microcirculation, which is particularly important for Long-Covid patients. So far, no negative side effects have been observed either. According to the management of Xlife, they are already in various discussions with possible industrial partners in order to have ProcCluster(R) industrially manufactured. The aim is for the active ingredient to be licensed out as quickly as possible. About Xlife Sciences AG Xlife Sciences AG is a Swiss company with focus on investing in promising technologies in the life science industry. Xlife Sciences AG is building the bridge from research and development to healthcare markets by supporting researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. Together with industrial partners or universities, Xlife Sciences AG leads projects through the proof-of-concept phase after an invention disclosure or start-up. Subsequently, the firm focuses on out-licensing or selling the company, often with a combination of a strategic partnership. Xlife Sciences AG offers its investors direct access to the further development of innovative and future-oriented technologies at a very early stage. For more information, please visit: www.xlifesciences.ch

Language:

English

Company:

Xlife Sciences AG

Klausstrasse 19

8008 Zürich

Switzerland

Phone:

0041 44 385 84 60

E-mail:

info@xlifesciences.ch

Internet:

www.xlifesciences.ch

ISIN:

CH0461929603

WKN:

A2PK6Z

Listed:

Regulated Unofficial Market in Frankfurt, Munich

EQS News ID:

1206317

End of Announcement DGAP News Service

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For media inquiries: Dennis Lennartz, Head Investor Relations, Xlife Sciences AG, Tel. +41 44 385 84 60, dennis.lennartz@xlifesciences.ch

For scientific inquiries: Dr. Frank Plöger, Chief Scientific Officer, Xlife Sciences AG, Tel. +41 44 385 84 62, frank.ploeger@xlifesciences.ch

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ferrari Selects AWS as its Official Cloud Provider to Power Innovation on the Road and Track18.6.2021 09:30:00 EEST | Press release

Today, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), announced that it has entered into an agreement with Ferrari S.p.A. to become their Official Cloud, Machine Learning, and Artificial Intelligence Provider. Together, the companies will accelerate the pace of innovation across the entire Ferrari organization, including their road cars department, GT Competitions, the Ferrari Challenge, and the Scuderia Ferrari FORMULA 1 (F1) team. Ferrari will use AWS’s breadth and depth of services and proven global infrastructure, including the AWS Europe (Milan) region, to streamline design and testing of its cars, giving customers the most exciting driving experiences possible. In addition, Scuderia Ferrari will leverage AWS to launch a digital fan engagement platform, via its mobile app, to engage hundreds of millions of fans worldwide with exclusive, personalized content. This press release features multimedia. View the full release here: https://www.businesswire.c

MATTR Now Available on Auth0 Marketplace18.6.2021 08:00:00 EEST | Press release

MATTR, a provider of verifiable data and digital trust solutions, today announced the availability of the MATTR VII platform on Auth0 Marketplace, a catalog of trusted technology integrations to extend the functionality of Auth0’s identity management platform. The MATTR VII platform provides an integrated approach to decentralised identity and data ownership. It decouples a user’s identity from their service providers, delivering significant benefits to users and giving builders and developers all the tools they need to create a whole new universe of decentralized products and applications. MATTR VII is composable and configurable to fit developers’ needs, whether it’s a well-established business with legacy systems or a start-up looking to build the next best thing in digital privacy. “MATTR is pleased to partner with Auth0, and welcomes Auth0’s recognition that MATTR’s approach to decentralised identity and data ownership can provide a powerful way to extend and enhance investment al

Bentley Systems Completes Acquisition of Seequent, Global Leader in 3D Modeling Software for the Geosciences17.6.2021 23:05:00 EEST | Press release

Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced the completion of its acquisition of Seequent Holdings Limited, for approximately $900 million in cash (for a debt free business and subject to final working capital adjustments) plus 3,141,342 BSY Class B shares. When announcing its second quarter 2021 operating results (scheduled for August 10, 2021) Bentley Systems will update its full‑year 2021 financial outlook, reflecting the inclusion of Seequent. About Bentley Systems Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry‑leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campus

Pattern Computer Develops Accurate 15-Second COVID-19 Test17.6.2021 23:03:00 EEST | Press release

Pattern Computer,® Inc. (PCI) has developed a novel test for near real-time (15 sec) diagnosis of SARS-CoV-2 infections. In contrast with widely used antibody and PCR tests, which take at least 15 minutes to produce results, and require scarce reagents to process, the newly developed PCI method enables high-volume throughput of tests without requiring chemical reagents at difficult to service locations, such as company entrances, event venues, court houses, state and federal facilities, TSA screening areas and ports of entry. “Having a simple, fast, easy to administer, high accuracy COVID-19 test will be critical for TSA and the airline carriers to increase passenger safety and confidence, as carriers deal with rising passenger loads and increased health security requirements,” said Bob Edwards, former CIO for United Airlines. “Pattern Computer’s new system appears to meet that need.” Developed using the Pattern Discovery Engine™ (PDE) comprised of proprietary software methods and spec

Lunaphore Appoints Dr. Carlo Bifulco to Scientific Advisory Board17.6.2021 18:00:00 EEST | Press release

Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment for cancer research, announces the appointment of Dr. Carlo Bifulco, an expert in Translational Molecular Pathology and Pathology Informatics, to its Scientific Advisory Board (SAB) to provide strategic advisory support to the company’s scientific activities and product portfolio development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210617005459/en/ Dr. Carlo Bifulco (Photo: Business Wire) Dr. Bifulco is a Surgical Pathologist with additional fellowship subspecialty training, expertise, and board certification in Molecular Genetic Pathology and Hematopathology. Dr. Bifulco serves on the Global Colon Cancer Immunoscore Task Force led by the Society for Immunotherapy of Cancer (SITC) and is co-Chair of the SITC Pathology Task convened to establish multiplexed immunohistochemistry/immunofluorescence (mIHC/IF) standards

Andersen Global Expands Into Four Caribbean Countries With CATC-HCC17.6.2021 16:30:00 EEST | Press release

Andersen Global enters into a Collaboration Agreement with tax and advisory firm CATC-HCC, bolstering its presence in the Caribbean with four additional locations in Aruba, Bonaire, Curaçao and St. Maarten. The CATC-HCC group of companies is led by Office Managing Partners Mireille de Miranda, Reint Roossien, Norman Henriquez and Jans Stam van Malsen, operating with more than 65 professionals. Headquartered in Aruba, the full-service firm provides tax and advisory services to individuals and businesses. “Our vision remains to be a benchmark organization and leading firm for financial business support in the region,” Mireille said. “Our clients operate both locally and in multiple jurisdictions, and collaborating with Andersen Global further supplements our service offerings and ability to deliver seamless, best-in-class services globally as we continue to create value for our clients.” “CATC-HCC provides broad regional and synergistic coverage as we continue to expand in the Caribbean,

Glamhive & Mary Kay Global Design Studio Announce First-Ever Global TikTok Reality Show Based on Style —Step & Repeat— Showcasing Talent in Wardrobe, Makeup & Hair from TikTok Users Worldwide17.6.2021 16:17:00 EEST | Press release

Today, Glamhive and Mary Kay Global Design Studio announce Step & Repeat, the first-ever style show launching on TikTok. Step & Repeat is a five-week style competition and mentorship program where wardrobe stylists, makeup artists, and hair stylists worldwide compete in the fast-paced environment of TikTok to drive their business success. The international competition is open to all and goes live on June 22 on TikTok. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210617005552/en/ CEO & Founder of Glamhive (Step & Repeat Co-Creator) Stephanie Sprangers (Photo: Mary Kay Inc.) TikTok's community has been growing at an incredible pace since the start of the pandemic, and unique new talents are being discovered daily on the platform. The most ambitious parlay their popularity into business opportunities, transforming entertainment into entrepreneurship, a mindset supported and lauded both by Glamhive and Mary Kay, particularly n

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom